42 CFR Subpart H
Payment for End-Stage Renal Disease (ESRD) Services and Organ Procurement Costs
June 11, 2020
§
413.177
Quality incentive program payment
§
413.178
ESRD quality incentive program
§
413.180
Procedures for requesting exceptions to payment rates
§
413.176
Amount of payments
§
413.170
Scope
§
413.171
Definitions
§
413.172
Principles of prospective payment
§
413.174
Prospective rates for hospital-based and independent ESRD facilities
§
413.182
Criteria for approval of exception requests
§
413.184
Payment exception: Pediatric patient mix
§
413.186
Payment exception: Self-dialysis training costs in pediatric facilities
§
413.194
Appeals
§
413.195
Limitation on Review
§
413.196
Notification of changes in rate-setting methodologies and payment rates
§
413.198
Recordkeeping and cost reporting requirements for outpatient maintenance dialysis
§
413.200
Payment of independent organ procurement organizations and histocompatibility laboratories
§
413.202
Organ procurement organization (OPO) cost for kidneys sent to foreign countries or transplanted in patients other than Medicare beneficiaries
§
413.203
Transplant center costs for organs sent to foreign countries or transplanted in patients other than Medicare beneficiaries
§
413.210
Conditions for payment under the end-stage renal disease (ESRD) prospective payment system
§
413.215
Basis of payment
§
413.217
Items and services included in the ESRD prospective payment system
§
413.220
Methodology for calculating the per-treatment base rate under the ESRD prospective payment system effective January 1, 2011
§
413.230
Determining the per treatment payment amount
§
413.231
Adjustment for wages
§
413.232
Low-volume adjustment
§
413.233
Rural facility adjustment
§
413.234.
Drug designation process
§
413.235
Patient-level adjustments
§
413.236
Transitional add-on payment adjustment for new and innovative equipment and supplies
§
413.237
Outliers
§
413.239
Transition period
§
413.241
Pharmacy arrangements